Defibrillator Market, By Component (Implantable Cardioverter Defibrillators (ICDs) and External Defibrillators (ED)Front), By Product Type, By End user, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4379
|
Published Date
October 2025
|
Pages
366
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Defibrillator Market size was valued at US$ 8,345.67 Million in 2024, expanding at a CAGR of 8.7% from 2025 to 2032.
A defibrillator is a medical device engineered to deliver a controlled electric shock to the heart in order to restore a normal heartbeat. It is primarily used in critical, life-threatening conditions such as ventricular fibrillation or pulseless ventricular tachycardia, where the heart’s electrical activity becomes disorganized or fails to effectively pump blood. By transmitting a high-energy pulse through the chest to the heart, the defibrillator can reset the heart’s rhythm, enabling it to resume normal contractions. These devices come in two main types: manual defibrillators, which require operation by trained healthcare professionals, and automated external defibrillators (AEDs), which are designed for use by laypersons during emergencies. Recognizing the importance of timely defibrillation, the World Health Organization (WHO) estimates that rapid access to AEDs could improve survival rates for sudden cardiac arrest victims by up to 70%, prompting many governments worldwide to invest in public access defibrillation programs and training initiatives.
Defibrillator Market- Market Dynamics
The expansion of emergency medical services with ambulances equipped with defibrillators is significantly improving survival rates.
The rapid expansion of emergency medical services (EMS) worldwide is playing a crucial role in enhancing survival rates for cardiac arrest patients. Across both urban and rural areas, ambulances equipped with advanced defibrillation technology provide immediate, life-saving interventions before patients reach hospitals. Since every minute without defibrillation significantly decreases the chances of survival, the integration of defibrillators into EMS fleets enables responders to initiate treatment within the critical “golden minutes,” substantially improving patient outcomes.
Governments globally are making substantial investments to upgrade EMS infrastructure—not only by increasing the number of ambulances but also by ensuring each vehicle is equipped with state-of-the-art automated external defibrillators (AEDs) or manual defibrillators. This enhancement is especially vital for rural and remote regions where access to hospitals can be delayed.
In addition, extensive training in advanced cardiac life support (ACLS) protocols is being provided to EMS personnel, empowering them to use defibrillators effectively and improve resuscitation success rates. The adoption of smart defibrillators with real-time patient monitoring and wireless data transmission is further boosting EMS capabilities. Some advanced devices can transmit patient ECG data directly to hospital emergency departments, allowing physicians to prepare for immediate intervention upon the patient’s arrival. This seamless pre-hospital to in-hospital care transition reduces treatment delays and improves overall outcomes.
For instance:
- In March 2024, the National Health Service (NHS) launched 300 newly built ambulances equipped with both advanced manual defibrillators and user-friendly AEDs. This major upgrade is part of a comprehensive initiative to strengthen pre-hospital cardiac emergency care, with a particular focus on reducing intervention times during sudden cardiac arrests, where rapid defibrillation is critical to survival.
Defibrillator Market- Segmentation Analysis:
The Global Defibrillator Market is segmented based on by component, by product type, by end user and region.
The market is segmented into two main categories based on component type: implantable cardioverter defibrillators (ICDs) and external defibrillators (EDs). Implantable cardioverter defibrillators dominate the market due to their proven effectiveness in continuously monitoring heart rhythms and delivering automatic life-saving interventions for patients at high risk of cardiac events. ICDs are widely prescribed for individuals with a history of ventricular fibrillation, ventricular tachycardia, or those facing significant risk of sudden cardiac arrest. Their ability to deliver precise electrical shocks internally, without requiring external intervention, makes them the preferred choice among cardiologists and healthcare providers. Recent technological advancements—such as miniaturization of devices, extended battery life, and enhanced remote monitoring capabilities—have further fueled the adoption of ICDs across hospitals and specialized cardiac care centers. According to the American Heart Association, cardiovascular diseases remain the leading cause of death globally, with sudden cardiac arrest accounting for over 350,000 deaths annually in the U.S. alone. Government healthcare programs and reimbursement policies that support ICD implantation have also been instrumental in expanding market growth, and ongoing innovations are expected to sustain ICDs’ market leadership throughout the forecast period.
The market is also divided into four end-user segments: hospitals, public access markets, alternate care markets, and home healthcare, with hospitals leading the market. Hospitals are at the forefront due to their critical role in managing sudden cardiac arrest and other cardiovascular emergencies. Equipped with advanced infrastructure, intensive care units, and highly skilled healthcare professionals, hospitals ensure the effective utilization of defibrillators. The high volume of patients requiring cardiac monitoring, along with increasing cardiac surgeries, further drives demand in this segment. Additionally, hospitals are early adopters of the latest defibrillation technologies, including automated external defibrillators (AEDs) and implantable devices, which improve patient outcomes significantly. Government investments in healthcare infrastructure and emergency response systems—such as the U.S. Health Resources and Services Administration’s funding for advanced cardiac care—bolster hospital capacity to manage cardiac emergencies. As the global burden of cardiovascular diseases continues to rise, hospitals are expected to remain the primary end-users driving the adoption of defibrillator technologies.
Defibrillator Market- Geographical Insights
Asia Pacific Dominates the Global Defibrillator Market in 2024
The Asia Pacific region is projected to lead the global defibrillator market in 2024, both in terms of revenue and market growth. This dominance is primarily driven by the rising prevalence of cardiovascular diseases, growing healthcare awareness, and rapid expansion of healthcare infrastructure in key countries such as China, India, Japan, and South Korea. Hospitals and specialized cardiac care centers are increasingly adopting Implantable Cardioverter Defibrillators (ICDs) and advanced External Defibrillators (EDs) to effectively manage sudden cardiac arrest and other critical conditions. Significant government investments in modernizing emergency medical services—including the deployment of defibrillator-equipped ambulances—have greatly improved timely access to cardiac care across urban and rural areas. For example, the Asia Pacific region accounts for nearly 40% of global cardiovascular disease-related healthcare expenditure, according to the World Health Organization (WHO), reflecting focused government efforts to combat the rising disease burden.
Public access defibrillation programs in major urban centers, alongside increased public education on preventive cardiac care, are further accelerating market growth. Technological innovations, such as miniaturized defibrillators, wearable devices, and remote monitoring systems, are broadening adoption in hospitals, outpatient care facilities, and home healthcare environments. Additionally, rising disposable incomes and favorable government policies supporting cardiovascular disease management make Asia Pacific an attractive and sustained growth market for defibrillator manufacturers throughout the forecast period.
North America to Register the Highest CAGR in the Defibrillator Market in 2024
North America is expected to record the highest compound annual growth rate (CAGR) in the global defibrillator market during the forecast period in 2024. This robust growth is fueled by the region’s advanced healthcare infrastructure, high cardiac care awareness, and widespread adoption of cutting-edge defibrillation technologies. The United States and Canada are witnessing increased investments in hospital upgrades, emergency medical services, and home healthcare solutions, boosting demand for both Implantable Cardioverter Defibrillators (ICDs) and External Defibrillators (EDs).
Large-scale public access defibrillation initiatives in schools, airports, sports arenas, and workplaces are improving emergency response times to sudden cardiac arrests. According to the American Heart Association, over 355,000 out-of-hospital cardiac arrests occur annually in the U.S., with survival rates improving due to expanded AED availability and public training programs. Technological advancements, including automated and wearable defibrillators with enhanced battery life and remote monitoring capabilities, are driving higher adoption in clinical and home care settings.
Supportive government policies—such as favorable reimbursement frameworks and insurance coverage for cardiac devices—along with initiatives to enhance pre-hospital emergency care, are encouraging widespread use of defibrillation technologies. The combination of these factors and the increasing prevalence of cardiovascular diseases firmly positions North America as the fastest-growing regional market by CAGR in the forecast period.
Defibrillator Market- Competitive Landscape:
The global defibrillator market is highly competitive, featuring a mix of established medical device manufacturers and innovative startups dedicated to advancing cardiac care solutions. Market players compete through technological innovation, product quality, geographic expansion, and strategic collaborations. The landscape is characterized by frequent product launches, mergers, acquisitions, and partnerships aimed at strengthening market positions and broadening regional reach.
Key companies are heavily investing in research and development to introduce next-generation defibrillators, including implantable cardioverter defibrillators (ICDs), wearable defibrillators, and semi-automatic and automated external defibrillators (AEDs). These innovations emphasize miniaturization, extended battery life, enhanced patient monitoring, mobile app connectivity, and real-time ECG transmission. By incorporating these advanced features, manufacturers seek to improve user-friendliness and clinical effectiveness, setting their products apart in a crowded marketplace.
Geographically, companies are expanding their footprint in emerging markets such as Asia Pacific, Latin America, and the Middle East, driven by rising cardiovascular disease prevalence, increasing healthcare expenditures, and government initiatives supporting pre-hospital cardiac care. Strategic alliances with hospitals, emergency medical service (EMS) providers, and public access programs further facilitate deeper market penetration.
In addition to innovation, competitive strategies include pricing, comprehensive after-sales service, and training programs to maintain customer loyalty and ensure proper device usage. Regulatory approvals and compliance from authorities such as the U.S. Food and Drug Administration (FDA), European CE marking, and other regional bodies remain critical factors shaping the competitive environment.
Recent Developments:
- In January 2025, the Australian government committed AUD 50 million to upgrade its national ambulance fleet with portable defibrillators and advanced patient monitoring devices. These portable systems empower EMS personnel to initiate life-saving interventions en route to hospitals, even in remote locations. The initiative aims to significantly boost survival rates for out-of-hospital cardiac arrest, which accounts for thousands of preventable deaths annually.
- In June 2024, Stryker launched the LIFEPAK 35 monitor/defibrillator, featuring advanced proprietary technologies on an intuitive, modern platform. Designed to provide healthcare professionals with rapid and accurate patient data during cardiac emergencies, the device’s integrated real-time ECG monitoring and enhanced defibrillation algorithms improve resuscitation success. This launch strengthens Stryker’s presence in both hospital and pre-hospital emergency care markets.
- In October 2024, MicroPort CRM received regulatory approval from China’s National Medical Products Administration (NMPA) for its PLATINIUM implantable cardioverter defibrillator (ICD). This marks the first domestically manufactured ICD in China to gain such clearance. The device offers continuous cardiac monitoring and automated shock delivery for patients at risk of sudden cardiac arrest, expanding access to advanced cardiac care across hospitals and specialty clinics nationwide.
- In October 2024, ZOLL announced that its AED Plus defibrillator received certification under the European Union Medical Device Regulation (EU MDR). This approval ensures compliance with stringent European safety and performance standards, enabling broader distribution throughout the EU. The AED Plus is designed for ease of use, rapid deployment, and improved survival outcomes in cardiac emergencies. Achieving EU MDR certification enhances ZOLL’s credibility and competitiveness in the European defibrillator market.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL DEFIBRILLATOR MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Abbott Laboratories
- Asahi Kasei Corporation
- BIOTRONIK SE & Co. KG
- Boston Scientific Corporation
- Cardiac Science Corporation
- CU Medical Systems, Inc.
- Fukuda Denshi Co., Ltd.
- Getinge Group
- LivaNova PLC
- Mediana Co. Ltd.
- Medtronic plc
- Metsis Medikal
- MicroPort Scientific Corporation
- Mindray Medical International
- Nihon Kohden Corporation
- Philips Healthcare
- Progetti Srl
- Schiller AG
- Stryker Corporation
- ZOLL Medical Corporation
- Others
GLOBAL DEFIBRILLATOR MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032
- Implantable Cardioverter Defibrillators (ICDs)
- External Defibrillators (ED)Front
- Others
GLOBAL DEFIBRILLATOR MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032
- S-ICD
- T-ICD
- Manual ED
- Automated ED
- Wearable Cardioverter Defibrillators
GLOBAL DEFIBRILLATOR MARKET, BY END USERS- MARKET ANALYSIS, 2019 - 2032
- Hospital
- Public Access Market
- Alternate Care Market
- Home Healthcare
GLOBAL DEFIBRILLATOR MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Defibrillator Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Defibrillator Market Snippet by Component
2.1.2. Defibrillator Market Snippet by Product Type
2.1.3. Defibrillator Market Snippet by End User
2.1.4. Defibrillator Market Snippet by Country
2.1.5. Defibrillator Market Snippet by Region
2.2. Competitive Insights
3. Defibrillator Key Market Trends
3.1. Defibrillator Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Defibrillator Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Defibrillator Market Opportunities
3.4. Defibrillator Market Future Trends
4. Defibrillator Industry Study
4.1. PESTEL Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Defibrillator Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Defibrillator Market Landscape
6.1. Defibrillator Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Defibrillator Market– By Component
7.1. Overview
7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
7.1.2. Implantable Cardioverter Defibrillators (ICDs)
7.1.3. External Defibrillators (ED)
8. Defibrillator Market– By Product Type
8.1. Overview
8.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
8.1.2. S-ICD
8.1.3. T-ICD
8.1.4. Manual ED
8.1.5. Automated ED
8.1.6. Wearable Cardioverter Defibrillators
9. Defibrillator Market– By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
9.1.2. Hospital
9.1.3. Public Access Market
9.1.4. Alternate Care Market
9.1.5. Home Healthcare
10. Defibrillator Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Defibrillator Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Defibrillator Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Defibrillator Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Defibrillator Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Defibrillator Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Defibrillator Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Abbott Laboratories
11.2.2. Asahi Kasei Corporation
11.2.3. BIOTRONIK SE & Co. KG
11.2.4. Boston Scientific Corporation
11.2.5. Cardiac Science Corporation
11.2.6. CU Medical Systems, Inc.
11.2.7. Fukuda Denshi Co., Ltd.
11.2.8. Getinge Group
11.2.9. LivaNova PLC
11.2.10. Mediana Co. Ltd.
11.2.11. Medtronic plc
11.2.12. Metsis Medikal
11.2.13. MicroPort Scientific Corporation
11.2.14. Mindray Medical International
11.2.15. Nihon Kohden Corporation
11.2.16. Philips Healthcare
11.2.17. Progetti Srl
11.2.18. Schiller AG
11.2.19. Stryker Corporation
11.2.20. ZOLL Medical Corporation
11.2.21. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
